These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15876995)

  • 21. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors].
    Drouet L
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral anticoagulant therapy in subjects with congenital or acquired thrombophilia.
    Baglin T
    Semin Vasc Med; 2003 Aug; 3(3):315-22. PubMed ID: 15199465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombophilia and cancer.
    Horowitz N; Brenner B
    Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited thrombophilia and venous thromboembolism.
    Simioni P; Tormene D; Spiezia L; Tognin G; Rossetto V; Radu C; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Update thrombophilia].
    Lindhoff-Last E; Luxembourg B; Pabinger I
    Hamostaseologie; 2008 Dec; 28(5):365-75. PubMed ID: 19132167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Venous thromboembolic disease: which coagulation screening, for whom, when?].
    Wautrecht JC
    Rev Med Brux; 2005 Sep; 26(4):S315-9. PubMed ID: 16240880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombophilia in children with venous thromboembolic disease.
    Revel-Vilk S; Kenet G
    Thromb Res; 2006; 118(1):59-65. PubMed ID: 15993476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J; Gompel A
    Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
    Wåhlander K; Eriksson H; Lundström T; Billing Clason S; Wall U; Nyström P; Wessman P; Schulman S;
    Br J Haematol; 2006 Apr; 133(1):68-77. PubMed ID: 16512831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombophilia and arterial disease. An up-to-date review of the literature for the vascular surgeon.
    Böhm G; Al-Khaffaf H
    Int Angiol; 2003 Jun; 22(2):116-24. PubMed ID: 12865876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and risk factors of venous thromboembolism.
    Ageno W; Squizzato A; Garcia D; Imberti D
    Semin Thromb Hemost; 2006 Oct; 32(7):651-8. PubMed ID: 17024592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
    Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
    Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
    Koutroubakis IE
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypercoagulable state as a risk factor for venous thromboembolism. Part 1.
    Dickey TL
    JAAPA; 2002 Nov; 15(11):28-32, 35. PubMed ID: 12474430
    [No Abstract]   [Full Text] [Related]  

  • 37. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does thrombophilia testing help in the clinical management of patients?
    Middeldorp S; van Hylckama Vlieg A
    Br J Haematol; 2008 Nov; 143(3):321-35. PubMed ID: 18710381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis.
    Harmanci O; Ersoy O; Gurgey A; Buyukasik Y; Gedikoglu G; Balkanci F; Sivri B; Bayraktar Y
    J Clin Gastroenterol; 2007; 41(5):521-7. PubMed ID: 17450038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombophilia risk factors evaluation in a group of Italian patients with deep venous thrombosis].
    Valverde S; Antico F; Trabuio E; Basso D; Navaglia F; Orlandini E; Giacomini A; Manoni F; Gessoni G
    Recenti Prog Med; 2008; 99(7-8):348-53. PubMed ID: 18751613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.